These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
661 related articles for article (PubMed ID: 9402107)
21. Evidence of epidermal growth factor receptor expression in uveal melanoma: inhibition of epidermal growth factor-mediated signalling by Gefitinib and Cetuximab triggered antibody-dependent cellular cytotoxicity. Amaro A; Mirisola V; Angelini G; Musso A; Tosetti F; Esposito AI; Perri P; Lanza F; Nasciuti F; Mosci C; Puzone R; Salvi S; Truini M; Poggi A; Pfeffer U Eur J Cancer; 2013 Oct; 49(15):3353-65. PubMed ID: 23849826 [TBL] [Abstract][Full Text] [Related]
22. Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis. Kuraya M; Yefenof E; Klein G; Klein E Eur J Immunol; 1992 Jul; 22(7):1871-6. PubMed ID: 1378022 [TBL] [Abstract][Full Text] [Related]
23. Cell-surface density of complement restriction factors (CD46, CD55, and CD59): oral squamous cell carcinoma versus other solid tumors. Ravindranath NM; Shuler C Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Feb; 103(2):231-9. PubMed ID: 17234541 [TBL] [Abstract][Full Text] [Related]
24. Tumor necrosis factor alpha increases and alpha-melanocyte-stimulating hormone reduces uveal melanoma invasion through fibronectin. Cantón I; Eves PC; Szabo M; Vidal-Vanaclocha F; Sisley K; Rennie IG; Haycock JW; MacNeil S J Invest Dermatol; 2003 Sep; 121(3):557-63. PubMed ID: 12925215 [TBL] [Abstract][Full Text] [Related]
25. Effect of periodontopathogen lipopolysaccharides and proinflammatory cytokines on CD46, CD55, and CD59 gene/protein expression by oral epithelial cells. Mahtout H; Curt S; Chandad F; Rouabhia M; Grenier D FEMS Immunol Med Microbiol; 2011 Aug; 62(3):295-303. PubMed ID: 21545652 [TBL] [Abstract][Full Text] [Related]
26. Cytokines and chemokines in the vitreous fluid of eyes with uveal melanoma. Nagarkatti-Gude N; Bronkhorst IH; van Duinen SG; Luyten GP; Jager MJ Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6748-55. PubMed ID: 22930720 [TBL] [Abstract][Full Text] [Related]
27. Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection. Montefiori DC; Cornell RJ; Zhou JY; Zhou JT; Hirsch VM; Johnson PR Virology; 1994 Nov; 205(1):82-92. PubMed ID: 7526538 [TBL] [Abstract][Full Text] [Related]
28. Heterogeneous response of human colon cancer cells to the cytostatic and cytotoxic effects of recombinant human cytokines: interferon-alpha, interferon-gamma, tumor necrosis factor, and interleukin-1. Morikawa K; Fidler IJ J Biol Response Mod; 1989 Apr; 8(2):206-18. PubMed ID: 2499665 [TBL] [Abstract][Full Text] [Related]
29. Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas. Mäenpää A; Junnikkala S; Hakulinen J; Timonen T; Meri S Am J Pathol; 1996 Apr; 148(4):1139-52. PubMed ID: 8644856 [TBL] [Abstract][Full Text] [Related]
30. Secretion of interleukin-6 and prostaglandin E2 during uveal melanoma-monocyte in vitro interactions. Cools-Lartigue J; Marshall JC; Caissie AL; Saraiva VS; Burnier MN Exp Eye Res; 2004 Oct; 79(4):451-4. PubMed ID: 15381029 [TBL] [Abstract][Full Text] [Related]
31. Membrane-bound complement regulatory proteins are prognostic factors of operable breast cancer treated with adjuvant trastuzumab: a retrospective study. Liu M; Yang YJ; Zheng H; Zhong XR; Wang Y; Wang Z; Wang YG; Wang YP Oncol Rep; 2014 Dec; 32(6):2619-27. PubMed ID: 25241923 [TBL] [Abstract][Full Text] [Related]
32. Induction of antibody-dependent cellular cytotoxicity in vivo by IFN-alpha and its antitumor efficacy against established B16 melanoma liver metastases when combined with specific anti-B16 monoclonal antibody. Eisenthal A; Cameron RB; Rosenberg SA J Immunol; 1990 Jun; 144(11):4463-71. PubMed ID: 2111349 [TBL] [Abstract][Full Text] [Related]
33. [Cytokines: current status and prospects in the treatment of skin tumors]. Nashan D; Luger TA Hautarzt; 2001 Aug; 52(8):691-6. PubMed ID: 11544938 [TBL] [Abstract][Full Text] [Related]
34. Expression of interleukin 1 alpha, interleukin 6, and tumor necrosis factor alpha genes in human melanoma clones is associated with that of mutated N-RAS oncogene. Castelli C; Sensi M; Lupetti R; Mortarini R; Panceri P; Anichini A; Parmiani G Cancer Res; 1994 Sep; 54(17):4785-90. PubMed ID: 8062279 [TBL] [Abstract][Full Text] [Related]
35. Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor. Hoon DS; Banez M; Okun E; Morton DL; Irie RF Cancer Res; 1991 Apr; 51(8):2002-8. PubMed ID: 1901239 [TBL] [Abstract][Full Text] [Related]
36. Effects of interferon alfa and gamma on human uveal melanoma cells in vitro. de Waard-Siebinga I; Creyghton WM; Kool J; Jager MJ Br J Ophthalmol; 1995 Sep; 79(9):847-55. PubMed ID: 7488605 [TBL] [Abstract][Full Text] [Related]
37. Effect of cytokines on the expression of cell adhesion molecule and on the adhesion of melanoma cells to endothelial cells. Kim SJ; Kim NS; Lee JL J Korean Med Sci; 1993 Feb; 8(1):41-52. PubMed ID: 8102061 [TBL] [Abstract][Full Text] [Related]
38. Tumorigenicity of the mixed spindle-epithelioid SP6.5 and epithelioid TP17 uveal melanoma cell lines is differentially related to alpha5beta1 integrin expression. Béliveau A; Bérubé M; Carrier P; Mercier C; Guérin SL Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):3058-65. PubMed ID: 11687555 [TBL] [Abstract][Full Text] [Related]
39. Anaphylatoxin receptors and complement regulatory proteins in human articular and non-articular chondrocytes: interrelation with cytokines. Schulze-Tanzil G; Kohl B; El Sayed K; Arens S; Ertel W; Stölzel K; John T Cell Tissue Res; 2012 Dec; 350(3):465-75. PubMed ID: 23053049 [TBL] [Abstract][Full Text] [Related]
40. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor. Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]